| Methods |
Randomised (no details of method given) parallel study. Duration 24 weeks. |
| Participants |
49 participants with CF. Mean (SD) age 33.4 (8) years. Mean (SD) baseline FEV1 % predicted 59.9 (21.5)% |
| Interventions |
Azithromycin either 1 g weekly (n=22) or 1.5 g 3x per week (n=27). |
| Outcomes |
Total adherence (total medication taken / total medication prescribed), total number of days adhered (number of days prescribed doses taken / number of days monitored), pill counts, pharmacy pick‐up, self‐reports using a Morisky and a Beliefs and Behaviour Questionnaire, FEV1 % predicted. |
| Notes |
Supported by ARC Linkage grant, Roche Australia Pty. Ltd |
